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Falls are the leading cause of both fatal and non-fatal injuries in people aged 65 years 
and older and can lead to significant costs, injuries, functional decline, and reduced 
quality of life. While certain medications are known to increase fall risk, medication 
use is a modifiable risk factor. Pharmacists have specialized training in medication 
management and can play an important role in fall prevention. Working in a patient-
centered team-based approach, pharmacists can collaborate with the primary care 
providers to reduce fall risk. They can screen for fall risk, review and optimize medication 
therapy, recommend vitamin D, and educate patients and caregivers about ways to 
prevent falls. To help health-care providers implement fall prevention, the Centers for 
Disease Control and Prevention developed the Stopping Elderly Accidents, Deaths, and 
Injuries (STEADI) initiative. Based on the established clinical guidelines, STEADI provides 
members of the health-care team, including pharmacists, with the tools and resources 
they need to manage their older patients’ fall risk. These tools are being adapted to 
specifically advance the roles of pharmacists in reviewing medications, identifying 
those that increase fall risk, and communicating those risks with patients’ primary care 
providers. Through a multidisciplinary approach, pharmacists along with other members 
of the health-care team can better meet the needs of America’s growing older adult 
population and reduce falls.
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tHe issUe
Falls are the leading cause of both fatal and non-fatal injuries in people aged 65 years and older 
and can lead to significant costs, injuries, functional decline, and reduction in the quality of life (1). 
In 2014, over 27,000 older adults died from a fall and 2.8 million more required treatment in emer-
gency departments for non-fatal injuries (1). Nevertheless, falling is not a normal part of aging and 
can be prevented.
Falls can be attributed to a number of modifiable risk factors including gait and balance problems, 
vitamin D deficiency, vision impairment, foot ailments, and medication use (2–4). Polypharmacy, 
known as the use of multiple medications or the administration of more medications than clini-
cally indicated, is common in older adults (5). Approximately 85% of older adults take at least one 
prescription medication and about 25% take five or more (6). Medications that affect the central 
nervous system can cause side effects that increase the chances of falling, such as dizziness, seda-
tion, confusion, blurred vision, and orthostatic hypotension (7–10). Medication classes strongly 
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associated with falls include anticonvulsants, antidepressants, 
antipsychotics, benzodiazepines, opioids, and sedative hypnotics 
(11). Benzodiazepines, including alprazolam and clonazepam, are 
prescribed in about 8% of older adults (12). During 2005–2010, 
roughly 5–7% of adults aged 60 years and older reported using 
hypnotics and sleep aids in the past 30 days (13). Additionally, 
when taken together, some of the aforementioned medications 
can have a synergistic effect on cognition and physical function, 
leading to a more pronounced fall risk (5, 14–17). Therefore, 
reviewing medications to see if medications can be stopped, 
switched, or reduced and managing those that may be clinically 
necessary are a key component to preventing older adult falls.
Many resources exist for use by health-care providers to 
optimize their patient’s medications and minimize polyphar-
macy and adverse events. Examples of resources include the 
Medication Appropriate Index (18), Beers criteria (11), Screening 
Tool of Older Person’s Prescriptions (STOPP)/Screening Tool 
to Alert doctors to Right Treatment (START) (19, 20), and the 
Anticholinergic Burden Index (21). While these tools exist, no one 
tool is all inclusive or considered the gold standard. Additionally, 
there is inconsistency among use of the tools. Therefore, each 
of these tools are helpful only when coupled with a thorough 
medication review by the primary care provider or if possible, 
a pharmacist.
Pharmacists are highly skilled in understanding how 
medications work individually or in combination to affect the 
body. Through a broad range of health-care services known as 
medication therapy management (MTM), pharmacists aim 
to ensure that each medication is the most effective and safest 
therapeutic option for a specific individual (22). Although MTM 
is a relatively new term, pharmacists have always been involved in 
medication review and management, despite their practice sites. 
A thorough medication review by a pharmacist includes a review 
of age-related physical changes that predispose older adults to 
drug–drug interactions, drug–disease interactions, and medica-
tion side effects that can increase the patient’s chances of falling 
(4, 23–25). For example, with age, the kidneys and liver may 
become less efficient, and the distribution of water and fat within 
the body changes. These physiological changes may affect the 
patient’s ability to metabolize medications, leading to exposure to 
higher doses, and an increased risk of adverse events. With every 
review, clinical pharmacists evaluate renal and hepatic functions 
to account for acute changes, modifying dose and/or frequency 
as needed (25, 26). In managing therapy, they consider health 
priorities and patient concerns, but always put patient safety and 
injury prevention as a priority.
To help health-care providers implement fall prevention, the 
Centers for Disease Control and Prevention (CDC) developed 
the Stopping Elderly Accidents, Deaths, and Injuries (STEADI) 
initiative. The initiative is specifically focused on reducing falls 
among community dwelling older adults and is based on the 
American and British Geriatrics Societies’ recommendations 
(27). STEADI provides members of the primary care team with 
the tools and resources they need to manage their older patients’ 
fall risk (28). The initiative encourages providers to take three 
initial steps to begin addressing their patients’ fall risks. They 
include (1) screening for fall risk by asking older adults if they 
have fallen in the past, feel unsteady, or are afraid of falling; 
(2) reviewing and managing their medications to determine if 
any increase fall risk and may need to be stopped, switched, or 
reduced; and (3) recommending vitamin D supplementation to 
improve bone, muscle, and nerve health.
While primary care physicians are trained on how to review 
and manage patients’ medications, research shows that physi-
cians often lack a framework on how to do so and therefore 
are inconsistent when conducting medication reviews (29). 
Comprehensive medication reviews have also been mistaken 
for medication reconciliations, in which a medication list is 
updated by comparing the medical record to an external list of 
medications obtained from a patient, hospital, or other provid-
ers, but not necessarily evaluated for appropriateness (30). To 
assist primary care providers in conducting a comprehensive 
medication review, which includes a medication reconciliation 
in the process, CDC has developed a consistent approach called 
the Screen, Assess, Facilitate, and Educate (SAFE) method as part 
of the STEADI resources for providers (www.cdc.gov/STEADI). 
SAFE highlights four essential steps in conducting a medication 
review to reduce fall risk. Focusing on the patient and caregiver, 
this method is adapted from two reputable pharmacist practice 
tools, the pharmacist’s MTM and patient care processes (22, 31), 
and encourages collaboration with a pharmacist.
cLiNicAL FALL PreveNtiON  
As A teAM-BAseD APPrOAcH
Population growth, the aging population, and insurance expan-
sions are projected to increase the demands for primary care 
physicians in the coming years (32). Due to time and resource 
constraints, the primary care physician’s ability to deliver preven-
tive clinical services is often affected by the need to address acute 
illnesses, chronic illnesses, and patient requests, among other 
demands (33). While primary care physicians can be trained to 
perform fall risk assessments, comprehensive medication reviews 
may require 30–45 min to complete and may be challenging to 
perform in busy primary care settings (29). Clinical fall prevention 
efforts do not need to be the sole responsibility of primary care 
physicians. Research shows that a collaborative multidisciplinary 
team can provide individualized patient interventions and reduce 
the rate and risk of falls (34, 35).
Trained specifically in pharmacotherapy and medication 
management, pharmacists have been effective in regularly 
reviewing medications, managing health conditions, provid-
ing education, and delivering direct patient care (36, 37). 
Pharmacist-provided direct patient care has favorable effects 
across various patient outcomes, health-care settings, and 
disease states (38). Through MTM, pharmacists have success-
fully reduced the number of fall-related medications, provided 
clinically significant recommendations, and educated patients 
(and care providing team members) about medications and the 
risk of falls (39–41). By  utilizing the expertise of additional 
health-care providers including nurses and pharmacists, the 
multidisciplinary team-based approach can alleviate some of 
the demands on primary care physicians while still ensuring 
optimal patient-centered care.
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In addition to offering MTM, pharmacists are well positioned 
to aid the health-care team in conducting other fall prevention 
services (42). A pharmacist, in collaboration with the primary 
care provider, can screen patients using a standardized protocol 
to determine fall risk, complete a thorough medication review, 
and recommend vitamin D supplementation (when appropriate). 
When conducting a thorough review, the pharmacist can work 
with the patients and caregivers to screen for medications that 
may increase fall risk, assess the patient to best manage health 
conditions, formulate the patient’s medication action plan, and 
educate the patient and caregiver about medication changes and 
fall prevention strategies. If screening indicates a patient is at risk 
of falling, the pharmacist can coordinate with the primary care 
team to arrange a complete fall risk assessment. Understanding 
the various roles pharmacists may play, CDC is exploring options 
to gain a better understanding of how pharmacists in each setting 
can cost effectively provide fall prevention services.
FUtUre stePs
Through the STEADI initiative, health providers, community 
organizations, and state health departments have come together 
to care for our older adult population. The CDC is currently 
developing educational tools and resources to specifically 
advance the role pharmacists and other health-care providers 
can play in providing fall prevention services. Pharmacists may 
be motivated to engage in fall prevention for various reasons. 
While incentives can vary within each practice site, incentives 
include job satisfaction, patient safety, improved patient care, and 
financial incentives. Reimbursement varies depending on state 
laws and practice sites but may be possible through collaborative 
practice agreements, MTM billing, or structured payment mod-
els. Nevertheless, CDC is exploring options to better understand 
incentives, successes, and barriers to implementation of fall 
prevention. Conducting focus groups with pharmacists practic-
ing in various sites, CDC is interested in understanding the falls 
related knowledge of pharmacists, learning potential barriers 
faced with providing fall prevention services, and developing a 
pharmacist-specific training on fall prevention services. CDC 
is also funding a project to learn best practices to improve col-
laboration and communication between community pharmacies 
and primary care offices. Through a multidisciplinary approach, 
pharmacists along with other members of the health-care team 
can better meet the needs of America’s growing older adult 
population and reduce falls.
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